Your browser is no longer supported. Please, upgrade your browser.
Settings
TLRY [NASD]
Tilray, Inc.
Index- P/E- EPS (ttm)-1.61 Insider Own2.00% Shs Outstand449.40M Perf Week-6.22%
Market Cap4.74B Forward P/E- EPS next Y-0.19 Insider Trans-17.79% Shs Float429.99M Perf Month-2.38%
Income- PEG- EPS next Q-0.05 Inst Own13.30% Short Float9.64% Perf Quarter-21.93%
Sales513.08M P/S9.23 EPS this Y36.60% Inst Trans8.12% Short Ratio2.01 Perf Half Y-39.63%
Book/sh9.61 P/B1.07 EPS next Y66.70% ROA- Target Price12.76 Perf Year20.59%
Cash/sh0.81 P/C12.59 EPS next 5Y49.30% ROE- 52W Range7.16 - 67.00 Perf YTD24.09%
Dividend- P/FCF- EPS past 5Y- ROI-5.50% 52W High-84.70% Beta2.49
Dividend %- Quick Ratio1.10 Sales past 5Y109.70% Gross Margin- 52W Low43.16% ATR0.81
Employees2100 Current Ratio1.60 Sales Q/Q226.80% Oper. Margin- RSI (14)40.76 Volatility6.65% 7.70%
OptionableYes Debt/Eq0.19 EPS Q/Q-416.60% Profit Margin- Rel Volume0.99 Prev Close10.57
ShortableYes LT Debt/Eq0.18 EarningsOct 07 BMO Payout- Avg Volume20.68M Price10.25
Recom2.80 SMA20-9.91% SMA50-8.29% SMA200-37.28% Volume20,371,981 Change-3.03%
Nov-18-21Initiated Barclays Underweight $10
Nov-01-21Downgrade Cantor Fitzgerald Overweight → Neutral $18 → $11.80
Jun-11-21Downgrade CIBC Sector Outperform → Neutral $25
Jun-03-21Upgrade Cantor Fitzgerald Neutral → Overweight $30.25 → $22
May-11-21Resumed Cowen Outperform $20
May-07-21Resumed Jefferies Buy $23
May-06-21Initiated Canaccord Genuity Hold $17
May-06-21Initiated Canaccord Genuity Buy $17
Apr-28-21Resumed BofA Securities Buy $23
Feb-18-21Downgrade The Benchmark Company Buy → Hold
Feb-18-21Downgrade Piper Sandler Overweight → Neutral $15 → $26
Nov-16-20Downgrade Jefferies Hold → Underperform $5.60 → $4.77
Nov-11-20Downgrade Stifel Hold → Sell $6 → $4.75
Oct-01-20Reiterated MKM Partners Neutral $8 → $6
Sep-21-20Upgrade Jefferies Underperform → Hold $5.60
May-12-20Reiterated The Benchmark Company Buy $28 → $14
Apr-16-20Downgrade Jefferies Hold → Underperform $5
Apr-09-20Downgrade Consumer Edge Research Overweight → Equal Weight
Feb-24-20Downgrade Cowen Outperform → Market Perform $40 → $20
Jan-13-20Initiated BofA/Merrill Neutral $18
Nov-29-21 01:01PM  
10:41AM  
08:28AM  
Nov-24-21 01:08PM  
Nov-23-21 09:02AM  
Nov-22-21 05:15PM  
03:12PM  
01:11PM  
Nov-21-21 07:55AM  
Nov-20-21 06:25AM  
Nov-19-21 05:23PM  
Nov-18-21 04:59PM  
01:30PM  
01:26PM  
08:54AM  
Nov-17-21 01:08PM  
Nov-16-21 02:34PM  
07:30AM  
Nov-15-21 05:49PM  
01:37PM  
12:06PM  
11:18AM  
Nov-14-21 08:42AM  
Nov-13-21 06:50AM  
Nov-12-21 02:15PM  
01:27PM  
11:07AM  
11:01AM  
Nov-11-21 12:43PM  
07:30AM  
Nov-10-21 12:40PM  
12:25PM  
Nov-08-21 06:03PM  
05:47PM  
01:53PM  
01:02PM  
Nov-05-21 02:17PM  
Nov-04-21 01:30PM  
07:30AM  
Nov-03-21 04:21PM  
Nov-02-21 07:22AM  
Nov-01-21 03:06PM  
07:11AM  
Oct-29-21 04:34PM  
05:59AM  
Oct-28-21 06:00AM  
Oct-26-21 02:49PM  
02:43PM  
01:53PM  
07:30AM  
Oct-22-21 03:07PM  
12:47PM  
06:00AM  
05:17AM  
Oct-21-21 12:08PM  
06:35AM  
06:17AM  
Oct-20-21 02:41PM  
01:02PM  
07:30AM  
05:18AM  
12:18AM  
Oct-19-21 04:35PM  
07:30AM  
Oct-14-21 01:39PM  
08:00AM  
06:33AM  
Oct-11-21 04:01PM  
07:00AM  
Oct-10-21 11:50AM  
10:25AM  
Oct-08-21 01:38PM  
07:31AM  
04:00AM  
01:47AM  
Oct-07-21 06:09PM  
05:27PM  
05:10PM  
02:43PM  
02:35PM  
01:01PM  
12:11PM  
10:00AM  
09:50AM  
07:47AM  
07:18AM  
07:02AM  
07:00AM  
06:26AM  
04:14AM  
03:58AM  
Oct-05-21 01:22PM  
12:08PM  
Oct-01-21 05:45PM  
Sep-30-21 05:50PM  
Sep-29-21 05:01PM  
Sep-27-21 08:07PM  
07:58PM  
05:36PM  
01:16PM  
Tilray, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. The company operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. It provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. The company offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Aphria Inc. Tilray, Inc. was incorporated in 2018 and is based in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kennedy BrendanDirectorAug 05Sale14.46300,0004,338,5707,974,196Aug 06 08:00 PM
Kennedy BrendanDirectorAug 04Sale14.08300,0004,224,2708,274,196Aug 06 08:00 PM
Kennedy BrendanDirectorJul 16Sale14.04300,0004,211,4308,574,196Jul 19 08:01 PM
Kennedy BrendanDirectorJul 15Sale14.67300,0004,400,8388,874,196Jul 19 08:01 PM
Kennedy BrendanDirectorJun 18Sale17.19400,0006,874,0409,174,196Jun 24 04:16 PM
Kennedy BrendanDirectorJun 17Sale17.97400,0007,186,6409,574,196Jun 24 04:16 PM
Merton Carl AChief Financial OfficerMay 14Option Exercise11.5641,500479,740210,605May 18 07:11 PM
Merton Carl AChief Financial OfficerMay 12Sale14.8289,0001,318,980169,105May 14 08:26 PM
St.Clare ChristineDirectorDec 16Sale10.002,20022,00018,646Dec 18 06:30 PM